BRIEF published on 04/03/2024 at 14:05, 2 years 6 months ago Clairvoyant Therapeutics Advances Psilocybin Clinical Trial for Alcohol Use Disorder Clinical Trial Clairvoyant Therapeutics Psilocybin Treatment Alcohol Use Disorder Regulatory Pathway
PRESS RELEASE published on 04/03/2024 at 14:00, 2 years 6 months ago Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization Clairvoyant Therapeutics aims to commercialize psilocybin treatment for alcohol use disorder by 2025. Company's trial progressing well, expecting results in 2024 & financing round underway Commercialization Clinical Trial Clairvoyant Therapeutics Psilocybin Treatment Alcohol Use Disorder
PRESS RELEASE published on 11/29/2023 at 13:00, 2 years 10 months ago Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder
PRESS RELEASE published on 03/20/2023 at 12:00, 3 years 7 months ago First Patient Dosed in Europe in Clairvoyant’s Phase 2b Clinical Trial Exploring Psilocybin Therapy as a Treatment for Alcohol Use Disorder
Published on 10/24/2026 at 00:04, 12 hours 4 minutes ago Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
Published on 10/23/2026 at 23:30, 12 hours 38 minutes ago Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita
Published on 10/23/2026 at 21:55, 14 hours 13 minutes ago Apex Closes Offering and Completes NASDAQ Listing
Published on 10/23/2026 at 16:00, 20 hours 8 minutes ago Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award
Published on 10/24/2026 at 06:30, 5 hours 37 minutes ago AI and EV Boom Draws $690 Million in Advanced Materials Investment Plans to Thailand
Published on 10/23/2026 at 18:55, 17 hours 12 minutes ago Qatar's Years of Culture Initiative Announces Partner Countries Through 2030
Published on 10/23/2026 at 18:00, 18 hours 8 minutes ago BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS AWARDED $5.7 MILLION TO ADVANCE DPP® BIOTHREAT PANEL
Published on 10/23/2026 at 17:55, 18 hours 13 minutes ago Hears Everything, Uploads Nothing: VoxNexus Launches Android's First Low-Power On-Device Always-On Voice Artificial Intelligence (AI)
Published on 10/23/2026 at 17:45, 18 hours 23 minutes ago Charwood Energy: Change to the Financial Calendar
Published on 10/23/2026 at 20:33, 15 hours 34 minutes ago Disclosure of transactions in own shares from October 19 to October 23, 2026
Published on 10/23/2026 at 17:45, 18 hours 23 minutes ago Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026
Published on 10/22/2026 at 18:00, 1 day 18 hours ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 1 day 18 hours ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
